FDA Inspection 853190 — Sandoz Incorporated

Sandoz Incorporated — FEI 1717759

The FDA completed an inspection of Sandoz Incorporated on October 17, 2013 in East Hanover, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 17, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Postmarket Surv. and Epidemiology
Location
East Hanover, NJ (United States)

Citations

IDCFRDescription
430321 CFR 211.67(b)Written procedures fail to include
440221 CFR 211.192Written record of investigation incomplete
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report